chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No reaction to the vaccine itself on the day. However around April 15th 2022, I did notice that I had some blood in my urine. My PCP looked into it and checked for urinary tract infections. They found no bacteria and then I was referred to a CT scan and a urologist. During my CT scan it showed a fairly large kidney stone and some smaller ones as well. The blood in my urine did clear up, and I was given a prescription after the discovery of kidney stones, Flomax on the 26th of April 2022. Symptoms did clear up quite a bit and I did have to wait until June to see the urologist. I did not have any blood in my urine at that point and the doctor recommended a sonogram of my kidneys and bladder. After doing so, it did not look like there was anything negative going on with my kidneys and believed that the stones may be blocking something in my kidneys. This past sunday, I had blood in my urine again and called my urologist and he asked if the blood comes back to see if I am passing kidney stones. I am also going to be doing another sonogram as well. A small amount of discomfort with the blood in urine however nothing serious.
About 2 wks post immun it was noted that on lt outer thigh a small dimple in the inject area had apeared; The area is now depressed in an area of about 2 1/2mm x 2 mm; No apparent pain, is able to bear weight;
HOT AND COLD FEELING; TERRIBLE FEELING; UNBELIEVABLE HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers No concomitant medications were reported. On an unspecified date, the subject experienced hot and cold feeling, terrible feeling, and unbelievable headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from hot and cold feeling, unbelievable headache, and terrible feeling. This report was non-serious.
Severe backpain; bad reaction; Diarrhea; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Severe backpain), ADVERSE REACTION (bad reaction), DIARRHOEA (Diarrhea), HEADACHE (Headache) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Severe backpain), ADVERSE REACTION (bad reaction), DIARRHOEA (Diarrhea), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, BACK PAIN (Severe backpain), ADVERSE REACTION (bad reaction), DIARRHOEA (Diarrhea), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Pt states that evening she experienced extreme diarrhea that continued for 3 days. She also states she had a headache that evening of the vaccination.  Her arm began to feel sore and states today arm is still very tender and sore.  Today 6/8/15 she had myself evaluate the area.  The area is bruised with an area in the center that is white.  Of note the area is warm to touch compared to lower arm.  The patients bicep also has noticeable swelling until about midpoint of the upper arm.
On 04/07 a little red at injection site-itchy. On 04/09 injection site red, few bumps around site, itchy. On 04/10 swollen at site, hard, warm-half dollar size. Keflex for 7 days 2x day. Still swollen at site but much improved.
Starting Tuesday, I felt blah and headachy and that lasted through the week. Saturday, 30th, I had vomiting, nausea, light headedness and dizziness- started 01:30 pm and lasted through the night. The next day, I still didn't feel well. Wednesday, the doctor's office called me to follow up. I had constant headaches and I went in, and my ears (inner) were filled with fluid. Saturday, I took Meclizine that I had. They prescribed more Meclizine, Zofran and nasal spray. Since this past Sunday, I have been doing good. I don't have the headaches now.
1st dose of Shingrix on 2019, and has not yet received the 2nd; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (received first dose on 20th August 2019 Batch number 4LH25 expiry date 30th September 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 09-AUG-2022. Reporter's Comments: The patient had not yet received the second dose.  The reporter gave consent to follow up. Additional Supportive Information: Till the time of reporting, the patient not received the second dose, which led to incomplete course of vaccination. The detail was reported for 1st dose.
An hour after vaccination- tingling lips, itchy ears, frequent urge to swallow, scratchy throat, chest tightening. Immediately began Benadryl. These symptoms persisted, so I continued Benadryl every 4 hours for 2 days.  On Saturday 01/30/2021, when symptoms continued.  She advised switching from Benadryl to  a once daily dose of Claritin and Pepcid AC. Switched to Claritin and Pepcid, symptoms persisted but started to diminish in severity. Planned appointment with Primary Care Physician is scheduled for 02/19/2021.
Patient stated that she experienced redness and swelling at injection site the same day she received the vaccine. Patient stated that redness and swelling escalated in addition to pain at the injection site on the evening of the following day upon receiving the vaccine.
Pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     The patient's past medical history included Concussion, Heart attack and Brain operation NOS. Concomitant products included TERIPARATIDE (FORTEO) and GABAPENTIN for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. On 25-Mar-2021, PAIN IN EXTREMITY (Pain in the arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's concomitant medications included heart medications and medications for recent brain surgery.   It was reported that the patient is scheduled for her second dose on 20-Apr-2021.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow up received on 19-AUG-2021,contains new information. Patient information, medical history, concomitant medicine and treatment medicine was updated and an event was added. On 02-Aug-2021: Non significant FU_Contact information updated and caller doesn't want safety to follow up with her on AE.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Vaccination has brought shingles back more so than ever, outbreak of the shingles is far worst than the original outbreak; More severe Excruciating pain; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HERPES ZOSTER (Vaccination has brought shingles back more so than ever, outbreak of the shingles is far worst than the original outbreak) and PAIN (More severe Excruciating pain) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     The patient's past medical history included Shingles. Concurrent medical conditions included Blood pressure high.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIZZINESS (dizziness). On an unknown date, the patient experienced HERPES ZOSTER (Vaccination has brought shingles back more so than ever, outbreak of the shingles is far worst than the original outbreak) and PAIN (More severe Excruciating pain). At the time of the report, DIZZINESS (dizziness), HERPES ZOSTER (Vaccination has brought shingles back more so than ever, outbreak of the shingles is far worst than the original outbreak) and PAIN (More severe Excruciating pain) outcome was unknown.            .   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Reporter information, historical condition and events added.
covid 19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (covid 19) in an 80-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (First Dose, Lot:EL9810) on 05-Feb-2021, PFIZER BIONTECH COVID-19 VACCINE (Third Dose, Lot: FF2588), PFIZER BIONTECH COVID-19 VACCINE (Second dose and Lot:EN6205); for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (Fourth Dose and  Lot: 005M21A). Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine, PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 22-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (covid 19). At the time of the report, COVID-19 (covid 19) had resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details not reported by the reporter. Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. On 15-APR-2022, patient received Moderna monovalent vaccine as additional booster dose with batch number 061F22A for COVID-19 prophylaxis indication. The patient explained that it may have been around 15-April-2022, because they caught COVID 10 days after booster dose.  Treatment details was not reported by the reporter.
ITCHY THROAT/FLUSHING OF THE SKIN/HEART PALPATION, SWEATING.
Menstrual cycle very heavy, comes earlier then normal, worse cramps. I've been regular my whole life and it wasn't until the vaccine that I have had extremely heavy periods (soaking through clothes and bed sheets), my cycles last longer and start earlier.
I felt as though my mind/head was in a total fog, my ability to concentrate on my job and other tasks had declined. This seemed to last for almost a week. Ive been a vitmain and mineral supplement intake for close to 3 months.
Received call from father 5/10/07 at 9:20 am. Patient has facial swelling, hand swelling, and rash. No redness or swelling at injection sites. Referred to Emergency Room after speaking with his primary MD.
This case was reported by a pharmacist via call center representative and described the occurrence of nausea in a adult male patient who received SHINGRIX (batch number 7A55L, expiry date 16th April 2021) for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX (subcutaneous). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced nausea, pain, muscle pain and intramuscular formulation administered by other route. On an unknown date, the outcome of the nausea, pain, muscle pain and intramuscular formulation administered by other route were unknown. It was unknown if the reporter considered the nausea, pain and muscle pain to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported however it could be 63 or 64 years. The patient probably received SHINGRIX subcutaneously, which led to incorrect route of vaccination. The patient had body aches and muscle aches. This is 1 of the 2 cases reported by the same reporter.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID Arm) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 immunization.     Concurrent medical conditions included Hypertension since June 1997, GERD since July 2000 and Osteoporosis since November 2002. Concomitant products included QUINAPRIL from July 1997 to an unknown date, LANSOPRAZOLE (PREVACID) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID Arm). At the time of the report, VACCINATION SITE REACTION (COVID Arm) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment information was provided.   This case was linked to MOD-2021-071278 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Reporter contact details were updated, patient demographic details were updated, current conditions were added, concomitant medications were added.
Pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    The patient's past medical history included Clinical trial participant (patient number : 89452). Concurrent medical conditions included Rheumatoid arthritis.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose once a week. On an unknown date, the patient experienced PAIN (Pain). At the time of the report, PAIN (Pain) outcome was unknown.            No information on concomitant medications was reported.  The patient took Humira 40 mg/0.4 mL once in 7 days (form : solution for injection in prefilled pen).  On an unknown date, the treatment with Humira was discontinued.  No information on treatment medications was reported.
Reported 2-3 hours after injection. Pt c/o numbness to fingers, pain up to the forearm. Left leg feels funny. Veins in arm bulging. On 10/30/03 veins still bulging. Arm is numb.
Within 48 hours post vax, the pt began to shake his head violently from side to side and jerk forward uncontrollably. Episodes lasted less than a minute and occurred many times a day for approximately 2.5 weeks before gradually subsiding. Pt also experienced a mild fever and slept restlessly during this time. In addition the pt had swollen lymph nodes, especially in the groin area.  The swelling was quite noticeable 2 weeks post vax.
Information has been received from a physician concerning a 79 year old retired white female with hypertension, hyperlipidemia and a codeine allergy who on approximately 16-AUG-2007 was vaccinated with Zostavax (Oka/Merck).  On 28-AUG-2007 (originally reported as approximately 16-AUG-2007) the patient experienced non painful, non pruritic, slightly erythematous macular rash.  The rash was bilateral on the patient's arms and legs.  There were no lesions on the trunk.  The physician stated that the rash was neither zoster-like or varicella-like.  Unspecified medical attention was sought.  As of 11-OCT-2007, the patient was recovered.  Additional information has been requested.
PC from MD, pt temp 101; pt would cry but no sound would come out of mouth; some local adenopathy @ inject site of DTP;
A few moments after receiving the Johnson & Johnson (Janssen ) vaccine I experienced a burning sensation across my chest.  I felt somewhat dizzy and disorientated. A few hours after the shot, I began to experience severe headaches, a fever of 101.5  - 102., and body aches through both of my legs which effected my movement.  My left arm is slightly bruised and I still have moderate pain in this arm.  I when to my primary physician who advised me to take Aleve and Tylenol which had little relief from the symptoms I was experiencing. My blood pressure was elevated to high-tension levels.
CAN'T PEE; CAN'T CRAP; IN BED ALL THE TIME; EYES ACHE/HURT IN EYES; FEELING REALLY SICK; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total, administered on 15-MAY-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced can't pee, can't crap, in bed all the time, eyes ache/hurt in eyes, and was feeling really sick. The patient's doctor would be coming on 16-JUL-2021.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the can't pee, can't crap, in bed all the time, eyes ache/hurt in eyes and feeling really sick was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210734547-Covid-19 vaccine ad26.cov2.s - CAN'T PEE. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
progressively inc swelling & redness no fever, eating well/sleep well;using arm well c/o pain 24hr ago;
24hr p/vax acute sever pharyngitis;72hr p/vax severe pharyngitis w/aphthous stomatitis;
mild arm pain, arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (mild arm pain, arm soreness) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced PAIN IN EXTREMITY (mild arm pain, arm soreness). At the time of the report, PAIN IN EXTREMITY (mild arm pain, arm soreness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-278822 (Patient Link).
This spontaneous report has been received from a nurse and refers to an unspecified number of patients of unknown ages and genders. The patients' medical histories, concurrent conditions, drug allergies/reactions, and concomitant therapies were not reported. The nurse reported that on unspecified dates, the patients were vaccinated with improperly stored doses of VARIVAX (lot # M028553, expiration date 07-JUN-2018; dose, route of administration, and frequency were not reported) for prophylaxis that were reconstituted with properly stored sterile diluent (DILUENT MRK) (lot number and expiration date were not reported). The vaccine data logger measured a temperature range from 6°F to 14°F for a total time frame of 30 min. There was no previous temperature excursion. No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1705USA003310:
Patient was given Pentacel vaccine with expiration date of 5/4/23 on 5/12/23. Manufacturer was contacted for guidance. Dose counted as invalid, will repeat dose.
March 24th 2021   1st Pfizer Covid 19 EP6955; Persistent fatigue since this Vaccination. April 21st   2021    2nd Pfizer Covid 19 EW0161 Vaccination  May 10th 2021      Singular Sudden Onset (20 min.) Intense R ForeheadNostril Pain  Persistent                                  Occipital Neuralgia 2 days later May 26th 2021      Occipital Neuralgia Pain Worsened with Intermittent Bilateral Lower Facial                                   Tingling & Numbness  particularly at the Chin -- Accompanied by a Low                                  Grade 100.4 Fever, Chills and a Shaking Legs Sensation. Extensive ER evaluation  May 26th 2021   continued ....  Extensive ER evaluation (+) mild transient lymphopenia,                                                          (+) strep rapid test (no sore throat) and tenderness of occipital                                                         nerves to palpation. Augmentin Rx.  Subsequent outpatient Occipital N. blocks  Abbreviated History:  Amidst all of this patient was having Progressive Random Brief Focal Deep Burning Pain  in the Arms & Fingers  Diffuse in the Legs, with "rash," Sensitive Skin, Dermatographia  & Hives.   On July 13th 2021 a Skin Biopsy also documented a Dx Progressive Pigmented Purpura  (rx triamcinilone). She's had eyelid swelling - blepharitis, mild R eye prominence and  intermittent R eye pain.  She's had transient (L) Little and (R) Index Finger proximal Joint  Nodules and persistent R Anterior Rib Pain. Since that time, the Facial Paresthesia persist  as intermittent Bilateral Chin Numbness. The Occipital Neuralgia Pain continues.   August--Sept 2021  Worsening Generalized Fatigue & Weakness. Early Satiety & 10 lb Weight Loss;  The areas of Progressive Pigmented Purpura are increasing, The Jabs of Deep Extremity Burning Pain  have Intensified in the Forearms and Thighs -- at times with painful ambulation. An Intermittent  Shaking Legs Sensation Continues.   She has Rare Shooting Pain up the sides of the throat to the pre-auricular areas.  Pressing on the Deep High Carotid & Digastric Triangles is Painful;  She has new  mild voice hoarseness in the last two weeks.
The patient developed a red, swollen area to the left deltoid. The area was warm to touch. the patient was treated with Benadryl and Tylenol. The patient's symptoms began 10/04/2001. The patient will go for follow up on 10/08/2001.